This ensures researchers can study GLP-1 therapies in populations that reflect real-world diversity, accounting for variations in age, ethnicity, socioeconomic status, and comorbid conditions
For most healthy adults, probiotics are considered safe to take alongside GLP-1 medications, and across dozens of clinical trials they've shown a safety profile comparable to placebo
Heres a quick breakdown of how the two formats differ: Dosing frequency: The pill is daily
Getting these medicines can sometimes be hard due to high demand and limited insurance coverage
Thirdly, GLP-1 agonists slow gastric emptying, leading to a delayed absorption of nutrients and a prolonged feeling of fullness, which can contribute to reduced food intake and weight loss